Cancers | Selected Papers on Cancer Immunotherapy Published in 2024

We are pleased to share a selection of papers from the 2024 collection on the topic “Cancer Immunotherapy: Mechanisms, Biomarkers, and Innovations”, published in the journal Cancers (ISSN: 2072-6694). Below is a list of high-quality articles that we believe you will find insightful and engaging.

1. “Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations”
by Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot, Roberto Bortolotti, Vito Racanelli, Orazio Caffo, Bruno Giometto, Alvise Berti and Antonello Veccia
Cancers 2024, 16(7), 1440; https://doi.org/10.3390/cancers16071440
Available online: https://www.mdpi.com/2072-6694/16/7/1440

2. “Dendritic Cells in Cancer Immunology and Immunotherapy”
by Laura Hato, Angel Vizcay, Iñaki Eguren, José L. Pérez-Gracia, Javier Rodríguez, Jaime Gállego Pérez-Larraya, Pablo Sarobe, Susana Inogés, Ascensión López Díaz de Cerio and Marta Santisteban
Cancers 2024, 16(5), 981; https://doi.org/10.3390/cancers16050981
Available online: https://www.mdpi.com/2072-6694/16/5/981

3. “Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings”
by Daniel Park, Won Jin Jeon, Chieh Yang and Dani Ran Castillo
Cancers 2024, 16(2), 318; https://doi.org/10.3390/cancers16020318
Available online: https://www.mdpi.com/2072-6694/16/2/318

4. “Hyperthermia in Combination with Emerging Targeted and Immunotherapies as a New Approach in Cancer Treatment”
by Tine Logghe, Eke van Zwol, Benoît Immordino, Kris Van den Cruys, Marc Peeters, Elisa Giovannetti and Johannes Bogers
Cancers 2024, 16(3), 505; https://doi.org/10.3390/cancers16030505
Available online: https://www.mdpi.com/2072-6694/16/3/505

5. “An Updated Review of Management of Resectable Stage III NSCLC in the Era of Neoadjuvant Immunotherapy”
by Saurav Verma, Daniel Breadner, Abhenil Mittal, David A. Palma, Rahul Nayak, Jacques Raphael and Mark Vincent
Cancers 2024, 16(7), 1302; https://doi.org/10.3390/cancers16071302
Available online: https://www.mdpi.com/2072-6694/16/7/1302

6. “Therapeutic Immunomodulation in Gastric Cancer”
by Venu Akkanapally, Xue-Feng Bai and Sujit Basu
Cancers 2024, 16(3), 560; https://doi.org/10.3390/cancers16030560
Available online: https://www.mdpi.com/2072-6694/16/3/560

7. “Biomarkers in the Diagnosis of Endometrial Precancers. Molecular Characteristics, Candidate Immunohistochemical Markers, and Promising Results of Three-Marker Panel: Current Status and Future Directions”
by Shuang Niu, Kyle Molberg, Diego H. Castrillon, Elena Lucas and Hao Chen
Cancers 2024, 16(6), 1159; https://doi.org/10.3390/cancers16061159
Available online: https://www.mdpi.com/2072-6694/16/6/1159

8. “The Immunomodulatory Effects of Fluorescein-Mediated Sonodynamic Treatment Lead to Systemic and Intratumoral Depletion of Myeloid-Derived Suppressor Cells in a Preclinical Malignant Glioma Model”
by Serena Pellegatta, Nicoletta Corradino, Manuela Zingarelli, Edoardo Porto, Matteo Gionso, Arianna Berlendis, Gianni Durando, Martina Maffezzini, Silvia Musio, Domenico Aquino et al.
Cancers 2024, 16(4), 792; https://doi.org/10.3390/cancers16040792
Available online: https://www.mdpi.com/2072-6694/16/4/792

You can view and submit relevant papers to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office